DODennis G. Osmond

Dennis G. Osmond

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dennis G. Osmond has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Liwei Lu

    Department of Pathology and Shenzhen Institute of Research and Innovation, The University of Hong Kong, Hong Kong, China

    4 shared publications
  • Duncan Lejtenyi

    Department of Anatomy and Cell Biology, McGill University, Montreal, Canada

    1 shared publication
  • Glennda Smithson

    Immunobiology and Cancer Program, Oklahoma Medical Research Foundation, Oklahoma City, USA

    1 shared publication
  • Liwei Lu

    Department of Anatomy and Cell Biology McGill University, Montreal, Canada

    1 shared publication
  • M. Suzanne Chappel

    Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, Canada

    1 shared publication
  • Paul W. Kincade

    Immunobiology and Cancer Program, Oklahoma Medical Research Foundation , Oklahoma City, OK 73104

    1 shared publication

Latest Publications

  • Melatonin inhibits apoptosis during early B‐cell development in mouse bone marrow

    by Qingnan Yu, Sandra C. Miller, Dennis G. Osmond

    The pineal secretory product, melatonin, exerts a variety of effects on the immune system. Administration of melatonin stimulates cell‐mediated immunity, particularly by inhibiting apoptosis among T lymphocytes in the thymus and inducing production of T‐cell‐derived cytokines. However, its possible effects on the humoral immune system are unclear. In the present study, we have examined whether melatonin may influence the in vivo development of B lymphocytes in mouse bone marrow, a process in which apoptosis is normally a prominent feature. Double immunofluorescence labeling and flow cytometry were used to quantitate phenotypically defined precursor B‐cell and mature B‐cell populations and their apoptotic rates in bone marrow of mice fed either melatonin‐containing or control diet for 16 days from 9 wk of age. In short‐term bone marrow cultures, the incidence of apoptosis among large pre‐B cells, including cells expressing the Λ5 component of pre‐B‐cell receptor, was markedly reduced in melatonin‐treated mice, associated with an increase in the absolute number of large pre‐B cells in bone marrow. In contrast, apoptosis of earlier precursor B cells and mature B lymphocytes did not differ from control values. The results indicate that orally administered melatonin can substantially promote the survival of precursor B cells in mouse bone marrow. Melatonin treatment may thus boost the survival of newly formed B cells mediating humoral immunity.


  • Open Access

    Regulation of cell survival during B lymphopoiesis: increased pre-B cell apoptosis in CD24-transgenic mouse bone marrow

    by Liwei Lu, M. Suzanne Chappel, R. Keith Humphries, Dennis G. Osmond

    CD24 (heat‐stable antigen) is expressed in a developmentally regulated fashion by B cell precursors in mouse bone marrow (BM), but its role in B lymphopoiesis remains obscure. A slight overexpression of CD24 in transgenic (Tg) mice leads to depletion of B lymphoid cells in BM. The present study examines whether CD24 is involved in apoptotic selection of B lineage cells under normal microenvironmental conditions in vivo. Double immunofluorescence labeling and flow cytometry have been used to quantitate the apoptotic rates of phenotypically defined B cell populations in BM of CD24‐Tg mice. Apoptosis of pre‐B cells expressing cytoplasmic μ heavy chains of IgM but lacking surface (s)IgM was increased both ex vivo and in short‐term culture, while the number of pre‐B cells was halved compared to BM of normal mice. In contrast, B220+μ – pro‐B cells and sIgM+ B lymphocytes showed no significant change in either apoptosis or number. The findings provide evidence that CD24 can play a role in vivo in modulating pre‐B cell apoptosis, a quality control checkpoint in B cell development.


  • Regulation of cell survival during B lymphopoiesis: suppressed apoptosis of pro-B cells in P53-deficient mouse bone marrow

    by Liwei Lu, Duncan Lejtenyi, Dennis G. Osmond

    B cell development in mouse bone marrow (BM) is subject to quality controls that eliminate aberrant cells by apoptosis, but the intrinsic cellular mechanisms that mediate this negative B cell selection remain unclear. The p53 tumor suppressor transduces signals resulting in apoptosis and cell cycle arrest in cells that sustain DNA damage. Faulty V(D)J recombination in scid lymphocyte precursors activates a p53-dependent DNA damage checkpoint. In the present study, we have examined whether p53 is involved in apoptotic selection of normally developing B cells in BM. Double immunofluorescence labeling and flow cytometry were used to quantitate phenotypically defined B cell populations and their apoptotic rates in BM of homozygous p53-deficient mice. B220+ μ− and terminal deoxynucleotidyl transferase (TdT)+ pro-B cells were increased in both incidence and absolute number to controls. In contrast, pre-B cells were only slightly increased and the sIgM+ B lymphocyte compartment remained essentially normal. The incidence of apoptosis among p53− / − pro-B cells was greatly reduced, both ex vivo and in short-term culture, whereas, apoptosis of pre-B cells and B lymphocytes was not significantly different from normal. The results indicate that p53 is actively involved as an apoptosis inducer at an early quality control checkpoint in B lymphopoiesis.


  • Open Access

    Regulation of Cell Survival During B Lymphopoiesis: Apoptosis and Bcl-2/Bax Content of Precursor B Cells in Bone Marrow of Mice with Altered Expression of IL-7 and Recombinase-Activating Gene-2

    by Liwei Lu, Prosanto Chaudhury, Dennis G. Osmond

    B cell development in mouse bone marrow depends critically upon IL-7. To examine the possible in vivo trophic role of IL-7, we have quantitated apoptosis and Bcl-2 family proteins in populations of phenotypically defined B lineage cells in IL-7-deficient and IL-7-overexpressing mice. Using immunofluorescence labeling, multiparameter flow cytometry, and a short-term culture assay, we show that the apoptotic rates of precursor B cells, but not of more mature B cells, are enhanced by IL-7 gene deletion, associated with increased intracellular content of Bax and decreased Bcl-2, while, conversely, an IL-7 transgene suppresses precursor B cell apoptosis and produces low Bax and high Bcl-2 levels. During normal B cell development, high Bax/Bcl-2 ratios characterize cells undergoing greatest apoptotic cell death. Pro-B cells in RAG-2−/− mice, all destined to abort, show elevated Bax levels and Bax/Bcl-2 ratios. By comparison with the elevated rate of pro-B cell apoptosis in RAG-2−/− mice, provisional estimates have been made for the fraction of pro-B cells undergoing apoptosis in normal mice (70%), IL-7−/− mice (85%), and IL-7 transgenic mice (35%). The results demonstrate that IL-7 strongly promotes in vivo cell survival and maintains antiapoptotic Bcl-2/Bax ratios during the development of precursor B cells in mouse bone marrow.


  • Open Access

    Two models of murine B lymphopoiesis: a correlation

    by Liwei Lu, Glennda Smithson, Paul W. Kincade, Dennis G. Osmond